Contributor Page
Smart & Biggar/Fetherstonhaugh
Email  |  Website  |  Articles
Contact Details
Tel: +1 416 5935514
Fax: +1 416 5911690
1100-150 York Street
ON M5H 3S5
By David Schwartz
The Government of Canada has opened a public consultation on proposed amendments to the Canadian Patent Rules, running from August 1 to September 8, 2017. The changes relate principally to pending amendments to the Patent Act intended to bring it into compliance with the Patent Law Treaty (PLT).
By Daniel Anthony, Timothy Stevenson
A pair of recent decisions under the Canadian Internet Registration Authority ("CIRA") Domain Name Dispute Resolution Policy ("CDRP") demonstrate that a trademark owner who fails to obtain a domain name transfer at a first panel hearing may nonetheless achieve a favourable outcome upon a second panel hearing.
By Daniel Hnatchuk
The Federal Court has issued its Further Judgment and Reasons concerning the amount of financial compensation to be paid to the Dow Chemical Company as a result of earlier patent infringement...
By Daniel Anthony
The Supreme Court of Canada issued its decision in Google v. Equustek, today, upholding an injunction requiring a non-party to an infringement action, Google, to remove links to infringing websites...
By Lynn Ing
The Supreme Court of Canada today delivered an important and highly anticipated decision, AstraZeneca Canada Inc v Apotex Inc, by rejecting the "promise doctrine" and clarifying...
By Renaud Garon Gendron, Ekaterina Tsimberis
On June 12, 2017, the Federal Court issued its 99-page decision in Diageo Canada Inc v Heaven Hill Distilleries Inc et al, 2017 FC 571.
By Jennifer Ponton
In a news release on June 7, the Government announced that it was suspending the implementation of the "private right of action" provisions in Canada's anti-spam legislation (CASL)...
By Smart & Biggar/Fetherstonhaugh
On April 28, 2017, the Federal Court released a Notice to the Parties and the Profession: Trial Management Guidelines.
By Smart & Biggar/Fetherstonhaugh
On March 28, 2017, CADTH published the fourth edition of the Guidelines for Economic Evaluation of Health Technologies: Canada, which set out the best practices for determining the economic value of health technologies.
By Smart & Biggar/Fetherstonhaugh
Proposed amendments to Food and Drug Regulations to enable importation of drugs that address an urgent public health need
By Smart & Biggar/Fetherstonhaugh
As reported here, on May 16, 2017, Minister of Health Jane Philpott announced a consultation regarding proposed amendments to the Patented Medicines Regulations that would significantly affect the PMPRB's approach to drug price evaluation.
By Smart & Biggar/Fetherstonhaugh
As previously reported here, Bill C-30 was passed by the Senate on May 11, 2017. Bill C-30 is the bill that will implement the Canada-European Union Comprehensive Economic and Trade Agreement (CETA).
By David Schwartz
On April 6, 2017, the Federal Court of Appeal overturned the Federal Court's finding that Apotex failed to mitigate the damage it incurred as the result of Health Canada's misfeasance in public office and negligence in its processing of Apotex's drug submission
By Smart & Biggar/Fetherstonhaugh
On April 28, 2017, the Supreme Court of Canada dismissed Apotex's application for leave to appeal a decision of the Federal Court of Appeal
By Lionel Fishman, Christine Genge
July 1, 2017, is Canada's 150th birthday. But it is also the deadline for taking certain actions in respect of pending Canadian design applications.